NYSE Fined $14 Million by SEC for Reg SCI Violations

The exchange settles after multiple investigations conducted into outages and systems issues over past several years.

nyse

The Securities and Exchange Commission (SEC) charges stem from five separate investigations—which include violations of Regulation Systems Compliance and Integrity (Reg SCI) and Regulation National Market System (Reg NMS) codes—and include NYSE, NYSE Arca and NYSE American, which neither admitted nor denied the findings in the SEC’s order.

The charges are significant because they represent the first filed for violations of Reg SCI, a series of rules designed to govern how securities exchanges

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

CME: CFTC OKs clearing move to Google Cloud

The CFTC has given the Chicago-based exchange approval to run its clearing and settlement infrastructure on the Google Cloud Platform, while the exchange and vendor have extended their partnership to last until at least 2037.

Cutting through the hype surrounding the FDTA rulemaking process

A bill requiring US regulators and institutions to adopt a machine-readable data framework for reporting purposes applies to entity identifiers, but not security identifiers, in a crucial difference, writes Scott Preiss, SVP and global head of Cusip Global Services.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here